Tech Company Financing Transactions
Decision Biomarkers Funding Round
Decision Biomarkers, based in Waltham, raised $7.6 million from Fletcher Spaght Ventures, Oxford Bioscience Partners and Rock Maple Ventures.
Transaction Overview
Company Name
Announced On
2/3/2006
Transaction Type
Venture Equity
Amount
$7,600,000
Round
Series A
Investors
Proceeds Purpose
This capital investment will enable Decision Biomarkers' management team to fast-track the use of the company's technology to reduce overall drug development costs for pharmaceutical companies that employ panels of protein biomarkers throughout the drug development process.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
150 Bear Hill Road
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Decision Biomarkers is a company that has developed an automated multiplex immunoassay platform and a biomarker panel assays for its lead product.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Jean Montagu
Chief Executive Officer
Roger Dowd
Chief Financial Officer
Charles Popkin
VP - Bus. Development
Joe Blanchard
VP - Engineering
Walter Leslie
VP - Marketing
Glenn Barney
VP - R & D
Peter Maimonis
Browse more venture capital transactions:
Prev: 2/2/2006: Certive venture capital transaction
Next: 2/5/2006: Mplicity venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs